We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-2.74%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.12B
AUM Growth
-$453M
Cap. Flow
-$364M
Cap. Flow %
-17.13%
Top 10 Hldgs %
34.33%
Holding
91
New
7
Increased
22
Reduced
20
Closed
19

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$27.3M
2
VEEV icon
Veeva Systems
VEEV
+$16.4M
3
IMGN
Immunogen Inc
IMGN
+$14.5M
4
DAWN
Day One Biopharmaceuticals
DAWN
+$14.1M
5
TSBX
Turnstone Biologics
TSBX
+$13.6M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$112M
2
PEN icon
Penumbra
PEN
+$46.5M
3
SYK icon
Stryker
SYK
+$35.2M
4
DVAX
Dynavax Technologies
DVAX
+$34.9M
5
UHS icon
Universal Health Services
UHS
+$26.3M

Sector Composition

Rank Sector Weight
1 Healthcare 96.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.04T
$160M 7.56%
298,643
– –
HUM icon
2
Humana
HUM
$47.7B
$80.8M 3.81%
166,066
– –
ABBV icon
3
AbbVie
ABBV
$448B
$74.7M 3.52%
501,192
-3,306
-0.7% -$485K
CYTK icon
4
Cytokinetics
CYTK
$11.2B
$70.7M 3.33%
2,399,545
– –
MRK icon
5
Merck
MRK
$315B
$61.4M 2.89%
596,261
– –
SGEN
6
DELISTED
Seagen Inc. Common Stock
SGEN
$59.7M 2.81%
281,617
+25,318
+10% +$5.06M
UNH icon
7
UnitedHealth
UNH
$392B
$58.5M 2.76%
116,067
– –
CAH icon
8
Cardinal Health
CAH
$51.7B
$55.5M 2.62%
639,783
– –
CNC icon
9
Centene
CNC
$32.5B
$54.4M 2.56%
789,868
-322,612
-29% -$21.5M
ICLR icon
10
Icon
ICLR
$12.9B
$52.6M 2.48%
213,559
– –
ARGX icon
11
argenx
ARGX
$53.3B
$51.5M 2.43%
104,732
– –
ISRG icon
12
Intuitive Surgical
ISRG
$121B
$50.3M 2.37%
172,043
– –
EW icon
13
Edwards Lifesciences
EW
$48.6B
$48.7M 2.29%
702,588
– –
BIIB icon
14
Biogen
BIIB
$29.2B
$48M 2.26%
186,635
-11,699
-6% -$3.13M
MOH icon
15
Molina Healthcare
MOH
$11.6B
$47.1M 2.22%
143,779
– –
PEN icon
16
Penumbra
PEN
$12.4B
$46.5M 2.19%
192,406
-167,624
-47% -$46.5M
IRTC icon
17
iRhythm Holdings
IRTC
$3.49B
$45.8M 2.16%
485,468
– –
LEGN icon
18
Legend Biotech
LEGN
$4.55B
$45.6M 2.15%
679,076
– –
BMRN icon
19
BioMarin Pharmaceuticals
BMRN
$11.3B
$44.1M 2.08%
498,280
+147,982
+42% +$13.2M
DHR icon
20
Danaher
DHR
$127B
$43.6M 2.05%
198,178
– –
MCK icon
21
McKesson
MCK
$95.3B
$42.4M 2%
97,498
-8,313
-8% -$3.5M
PRTA icon
22
Prothena Corp
PRTA
$442M
$40.4M 1.9%
836,571
+62,025
+8% +$3.68M
BDX icon
23
Becton Dickinson
BDX
$42.2B
$39.8M 1.88%
153,955
– –
IQV icon
24
IQVIA
IQV
$33.1B
$39.6M 1.86%
201,037
– –
SNDX icon
25
Syndax Pharmaceuticals
SNDX
$1.95B
$39.4M 1.86%
2,715,235
+542,798
+25% +$10.3M
1
2 3 4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return

PFM Health Sciences's Q3 2023 Portfolio in Review

As of Q3 2023, PFM Health Sciences held 91 positions worth $2.12B, down 18% from $2.58B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

PFM Health Sciences withdrew a net $364M in Q3 2023, closing 19 positions and reducing 20 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $112M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier.

Against the trend, PFM Health Sciences opened a new position in Lantheus worth $25.9M.

  • PFM Health Sciences's largest Q3 2023 buy was Lantheus: 372,761 shares worth $25.9M.
  • PFM Health Sciences added most to Veeva Systems in Q3 2023, an estimated $16.4M increase.
  • PFM Health Sciences's biggest Q3 2023 reduction was Penumbra, cutting an estimated $46.5M.
  • PFM Health Sciences fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2023, selling an estimated $112M.
  • PFM Health Sciences's ten largest holdings make up 34% of its $2.12B portfolio in Q3 2023.
  • PFM Health Sciences opened 7 new positions and closed 19 in Q3 2023.
  • PFM Health Sciences's portfolio value fell 18% quarter-over-quarter to $2.12B.

Based on PFM Health Sciences's 13F filing for Q3 2023, filed 14 Nov 2023.